Bath & Body Works, Inc. filed its Form 10-Q for the quarterly period ended October 31, 2026 with the U.S. Securities and Exchange Commission on November 19, 2026, covering the company's third fiscal quarter results.
Key Highlights
- Net sales of $1,577 million in the third quarter of 2026, compared to $1,594 million in the third quarter of 2025, according to the filing.
- Net income of $38 million for the third quarter of 2026, down from $77 million in the same period of 2025, the company reported.
- Year-to-date net income of $339 million for the thirty-nine weeks ended October 31, 2026, compared to $246 million in the year-to-date 2025 period.
- Diluted earnings per share of $0.19 for the third quarter of 2026, versus $0.37 in the prior-year quarter.
- Cash dividend of $0.20 per share was declared in the third quarter of 2026, the same amount as in the third quarter of 2025.
- Common shares outstanding of 197,824,759 as of November 13, 2026, as stated on the cover page of the filing.
- Long-term debt of $3,367 million as of October 31, 2026, reduced from $3,890 million as of November 1, 2025.
Bath & Body Works Third-Quarter 2026 Financial Results
According to the filing, Bath & Body Works reported net sales of $1,577 million for the thirteen-week period ended October 31, 2026, a decrease from $1,594 million in the comparable prior-year quarter. Gross profit was $638 million in the third quarter of 2026, compared to $658 million in the third quarter of 2025. General, administrative and store operating expenses increased to $530 million from $497 million year over year, the company disclosed. Operating income for the quarter was $108 million, down from $161 million in the third quarter of 2025.
For the year-to-date period of thirty-nine weeks ended October 31, 2026, the filing reported net sales of $4,469 million versus $4,567 million in the prior-year period. Year-to-date operating income was $555 million, compared to $527 million in year-to-date 2025. Net income on a year-to-date basis was $339 million, or $1.68 per diluted share, against $246 million, or $1.17 per diluted share, in the same period of 2025.
On the balance sheet, the company disclosed total assets of $5,089 million as of October 31, 2026. Cash and cash equivalents stood at $318 million, down from $953 million at January 31, 2026. Inventories were $1,281 million as of October 31, 2026, compared to $699 million at January 31, 2026. The company repurchased 3 million shares of common stock during the third quarter of 2026 at a cost of $60 million, according to the equity statement. Total shareholders' equity (deficit) was $(1,111) million at the end of the quarter. The filing also noted that the company is listed on NYSE:BBWI.
What Was Disclosed
Bath & Body Works filed its quarterly report covering the thirteen-week period ended October 31, 2026, disclosing lower third-quarter net income and net sales compared to the prior-year quarter, alongside year-to-date net income growth and balance sheet changes including reduced long-term debt.


Please wait processing your request...